期刊文献+

儿童重症支原体肺炎的临床特征和治疗分析 被引量:2

Analysis of clinical features and treatment of children with severe mycoplasma pneumonia
原文传递
导出
摘要 目的通过临床案例观察儿童重症支原体肺炎的临床特征,并探讨治疗方案。方法收集分析2010年3月至2011年10月的79例就诊的儿童重症支原体肺炎患者,回顾患者的临床症状和体征,以及治疗经过和预后转归。结果本文重症支原体肺炎主要以咳嗽、咳痰、发热为主要临床特征,有78.3%的患者出现肺外并发症,联合使用抗生素,辅以糖皮质激素或丙种球蛋白治疗,总有效率为87.50%,在临床上取得了良好的治疗效果。结论儿童重症支原体肺炎临床表现及其并发症严重,采取联合使用抗生素及糖皮质激素或丙种球蛋白治疗在临床上具有重要意义。 Objective To observe the clinical features of children with severe mycoplasma pneumonia,to explore treatment options.Methods Collected and analyzed from March 2010 to October 2011 79 patients in our department treatment of children with severe mycoplasma pneumonia patient records,then review the patient's clinical symptoms and signs,and treatment outcome and prognosis.Results This results mainly in severe mycoplasma pneumonia cough,sputum,fever as the main clinical features,78.3% of patients with pulmonary complications,the joint use of antibiotics,combined with corticosteroids or immunoglobulin therapy,achieved a good clinical therapeutic effect.Conclusions Children with severe clinical manifestations and complications of mycoplasma pneumonia severe joint use of antibiotics and corticosteroids or immunoglobulin therapy has important clinical significance.
作者 杨勇
出处 《医药论坛杂志》 2011年第24期16-17,共2页 Journal of Medical Forum
关键词 儿童 重症 支原体肺炎 临床特征 治疗方案 Children Severe Mycoplasma pneumonia Clinical features Treatment
  • 相关文献

参考文献4

二级参考文献31

  • 1董宗祈.小儿肺炎支原体感染的临床表现[J].实用儿科杂志,1993,8(3):199-200. 被引量:75
  • 2[1]Keiskanen-Kosma T,Korppi M,Jokinen C,et al.Etiology of childhood pneumonia: serologic results of a prospective,population-based study[J].Pediatr Infect Dis,1998,17(11):986-991.
  • 3[2]SuCJ,Dallo SF,Baseman JB,et al.Possible origin of sequence divergence in the P1 cytadhesin gene of mycoplasma pneumoniae[J].Infect Immun,1993,61:816-822.
  • 4[3]Cole BC.Mycoplasma interactions with the immune system:implications for disease pathology[J].ASM News,1996,62:471-475.
  • 5[4]TanaKa H,Koba H,Honma S,et al.Relationships between radiological pattern and cell-mediated immune response in mycoplasma pneumoniae pneumonia[J].Eur Respir,1996 ,9(4):669-672.
  • 6[5]Romero Rojas A,Ponce Hernandez C,Ciprian A,et al.Immunomodulatory properties of mycoplasma pulmonisⅠcharacterization of the immunomodulatory activity[J].Int Immunopharmacol,2001 ,1(9-10):1679-1688.
  • 7[6]Tanaka H,Abe S,Tamura H.Pathological changes by the imbalance of host T helper lymphocyte subsets in mycoplasma pulmonis pneumonia of mice[J].Kansenshogaku Zasshi,1998 ,72(4):342-346.
  • 8[7]Koh YY,Park Y,Lee HJ,et al.Levels of IL-2,IFN-r,IL-4 in BLF From patients with mycoplasma pneumonia[J].Pediatrics,2001 ,107(3):E39.
  • 9[8]Romero-Rojas A,Ponce-Hernandez C,Mendoza SE,et al.Immunomodulatory properties of mycoplasma pulmonis Ⅱstudies on the mechanisms of immunomodulation[J].Int Immunopharmacol,2001 ,1(9-10):1689-1697.
  • 10[9]Walker J,Lee R,Mathy N,et al.Restricted B-cell responese to microbial challenge of the respiratroy tract[J].Vet Immunol Immunopathol,1996,54(1-4):197-204.

共引文献314

同被引文献2

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部